Skip to content
Saturday, November 7, 2026
Future Club Hub

Patients Coming Off Slimming Injections Put On Weight at a Quadrupled Rate Than Dieters

Illustration of pharmaceutical injection and weighing machine
Weight management often requires ongoing approaches.

Fresh analysis indicates that people who discontinue popular GLP-1 drugs like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who end traditional diet and exercise regimens.

Published data in a major medical journal points out that while obese people frequently drop a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals using such medications should be cognizant of the potential of rapid weight regain when the therapy ends," stated expert Dr. Susan Jebb.

This pace of recovery suggests a reversion to original weight within about a year and a half.

Analyzing Treatments

The study, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with other pills.

Scientists point out that people who shed pounds through dieting typically experience a less rapid weight regain—perhaps 100 grams monthly—post-intervention.

The Reason for the Rapid Rebound

Doctors suggest the mode of action of the injections accounts for the heightened weight return.

These medications copy a natural hormone called GLP-1, which controls appetite.

"Sustained high doses of the hormone concentrations far above than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this hormone supplement results in hunger is unsuppressed, making binge eating much more probable."

An Ongoing Condition?

Medical guidelines advise the injections for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.

Professionals contend that, given the likelihood of relapse, the treatment should be considered long-term.

This view is echoed by pharmaceutical companies, who say that the results "underscore the long-term character of excess weight," similar to managing conditions like high blood pressure.

User Experiences

Individuals who have come off the jabs explain a powerful resurgence of cravings.

"I experienced a switch flipping and you become extremely hungry," said an individual.

This difficulty is worsened if patients have not adopted sustainable dietary or behavioural changes during treatment.

Significant Adoption

Recent estimates indicate that millions of adults in the UK have used weight-loss jabs in the past year, with interest continuing to grow.

  • Adoption is greater among women than men.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion access the medications through private healthcare rather than public health services.

Finally, experts caution that while the jabs are effective agents for shedding pounds, they are not a standalone solution and maintained weight loss hinges on ongoing lifestyle support.

The writer

Luis Johnson

Elara Vance is a tech futurist and writer with a passion for exploring how emerging technologies shape society and daily life.

Future Club Hub

Type to search articles.